Laura Kresty

Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis.

G. T. Budd, E. Hawk, G. Kelloff, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.